These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 28068873)

  • 21. Survival and prognostic factors of anaplastic thyroid carcinoma.
    Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
    Acta Chir Belg; 2015; 115():62-7. PubMed ID: 26021793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF
    Zhao X; Wang JR; Dadu R; Busaidy NL; Xu L; Learned KO; Chasen NN; Vu T; Maniakas A; Eguia AA; Diersing J; Gross ND; Goepfert R; Lai SY; Hofmann MC; Ferrarotto R; Lu C; Gunn GB; Spiotto MT; Subbiah V; Williams MD; Cabanillas ME; Zafereo ME
    Thyroid; 2023 Apr; 33(4):484-491. PubMed ID: 36762947
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
    Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ
    Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathologic Features and Clinical Outcome of Anaplastic Thyroid Carcinoma with a Minor Anaplastic Component.
    Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
    Endocr Pathol; 2020 Sep; 31(3):283-290. PubMed ID: 32445173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases.
    Liu TR; Xiao ZW; Xu HN; Long Z; Wei FQ; Zhuang SM; Sun XM; Xie LE; Mu JS; Yang AK; Zhang GP; Fan Y
    PLoS One; 2016; 11(10):e0164840. PubMed ID: 27760217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis.
    Kim SY; Kim SM; Kim JW; Lee IJ; Jeon TJ; Chang H; Kim BW; Lee YS; Chang HS; Park CS
    Front Endocrinol (Lausanne); 2020; 11():599. PubMed ID: 32982983
    [No Abstract]   [Full Text] [Related]  

  • 27. Anaplastic thyroid carcinoma: a 25-year single-institution experience.
    Mohebati A; Dilorenzo M; Palmer F; Patel SG; Pfister D; Lee N; Tuttle RM; Shaha AR; Shah JP; Ganly I
    Ann Surg Oncol; 2014 May; 21(5):1665-70. PubMed ID: 24554064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
    Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
    Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation-based, short-term "neoadjuvant" treatment allows resectability in stage IVB and C anaplastic thyroid cancer.
    Maurer E; Eilsberger F; Wächter S; Riera Knorrenschild J; Pehl A; Holzer K; Neubauer A; Luster M; Bartsch DK
    Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1509-1518. PubMed ID: 36637521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer.
    Saeed NA; Kelly JR; Deshpande HA; Bhatia AK; Burtness BA; Judson BL; Mehra S; Edwards HA; Yarbrough WG; Peter PR; Holt EH; Decker RH; Husain ZA; Park HS
    Head Neck; 2020 May; 42(5):1031-1044. PubMed ID: 32011055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival and Prognostic Factors of Anaplastic Thyroid Carcinoma.
    Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
    Acta Chir Belg; 2015 Jan; 115(1):62-7. PubMed ID: 27384898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer.
    Prasongsook N; Kumar A; Chintakuntlawar AV; Foote RL; Kasperbauer J; Molina J; Garces Y; Ma D; Wittich MAN; Rubin J; Richardson R; Morris J; Hay I; Fatourechi V; McIver B; Ryder M; Thompson G; Grant C; Richards M; Sebo TJ; Rivera M; Suman V; Jenkins SM; Smallridge RC; Bible KC
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4506-4514. PubMed ID: 29029287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaplastic thyroid cancer: An update.
    Rao SN; Smallridge RC
    Best Pract Res Clin Endocrinol Metab; 2023 Jan; 37(1):101678. PubMed ID: 35668021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
    Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
    Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma.
    Qin Y; Wang JR; Wang Y; Iyer P; Cote GJ; Busaidy NL; Dadu R; Zafereo M; Williams MD; Ferrarotto R; Gunn GB; Wei P; Patel K; Hofmann MC; Cabanillas ME
    Thyroid; 2021 Aug; 31(8):1235-1243. PubMed ID: 33599171
    [No Abstract]   [Full Text] [Related]  

  • 36. A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.
    Chintakuntlawar AV; Yin J; Foote RL; Kasperbauer JL; Rivera M; Asmus E; Garces NI; Janus JR; Liu M; Ma DJ; Moore EJ; Morris JC; Neben-Wittich M; Price DL; Price KA; Ryder M; Van Abel KM; Hilger C; Samb E; Bible KC
    Thyroid; 2019 Nov; 29(11):1615-1622. PubMed ID: 31595822
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic factors for Korean patients with anaplastic thyroid carcinoma.
    Kim TY; Kim KW; Jung TS; Kim JM; Kim SW; Chung KW; Kim EY; Gong G; Oh YL; Cho SY; Yi KH; Kim WB; Park DJ; Chung JH; Cho BY; Shong YK
    Head Neck; 2007 Aug; 29(8):765-72. PubMed ID: 17274052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: a real-world experience.
    Park J; Jung HA; Shim JH; Park WY; Kim TH; Lee SH; Kim SW; Ahn MJ; Park K; Chung JH
    Eur J Endocrinol; 2021 May; 184(6):837-845. PubMed ID: 33852431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
    Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
    Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaplastic thyroid cancer: a case report of a long term survival patient and review of literature data.
    Ursino S; Fiorica F; Stefanelli A; Pedriali M; Colosimo C; Cocuzza P; Mazzotti V; Taibi R; Cartei F; Greco C
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1368-72. PubMed ID: 24867515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.